RESUMO
The article presented a clinical case of 8-year follow-up of a patient with a relatively beneficial course of pulmonary sarcoidosis and intrathoracic lymph nodes and with gradually progressing myocardial injury. A specific feature of the case was that the patient had monoclonal gammopathy, which is extremely rarely reported. Morphological signs of paraproteinemic hemoblastosis and amyloidosis were not observed. The article considered a whole complex of studies, which is required for diagnosing cardiac sarcoidosis in a specific patient and addressed the issue of monoclonal gammopathy origination.
Assuntos
Paraproteinemias , Sarcoidose , Cardiomiopatias , Coração , HumanosRESUMO
Chronic obstructive pulmonary disease (COPD) is the fourth largest cause of worldwide mortality. Presence of comorbidities is registered in 96% of COPD patients. The most important of these are cardiovascular diseases (coronary artery disease, arterial hypertension, chronic heart failure), which contribute to COPD patients' mortality in every third case. COPD and cardiovascular diseases have common risk factors and pathogenesis mechanisms. Cardioselective beta-blockers reduce morbidity risk and frequency of COPD exacerbation, are effective and safe in treatment of COPD patients.
Assuntos
Doenças Cardiovasculares , Insuficiência Cardíaca , Doença Pulmonar Obstrutiva Crônica , Antagonistas Adrenérgicos beta , Doenças Cardiovasculares/epidemiologia , Comorbidade , Humanos , Doença Pulmonar Obstrutiva Crônica/epidemiologiaRESUMO
In this article we present a clinical case of a quick recovery and restoration of pulmonary function after withdrawal of amiodarone in a patient with drug-associated acute lung injury induced by intake of amiodarone for two months.
Assuntos
Lesão Pulmonar Aguda , Amiodarona/efeitos adversos , Lesão Pulmonar Aguda/induzido quimicamente , Antiarrítmicos , Humanos , PulmãoRESUMO
A case of the treatment of a patients with idiopathic pulmonary fibrosis with pirfenidone and nintedanib is reported with reference to the role of these medications in therapy of his condition in the context of modern theory of its pathogenesis.
Assuntos
Fibrose Pulmonar Idiopática , Indóis/administração & dosagem , Piridonas/administração & dosagem , Idoso , Anti-Inflamatórios não Esteroides/administração & dosagem , Progressão da Doença , Monitoramento de Medicamentos/métodos , Quimioterapia Combinada , Humanos , Fibrose Pulmonar Idiopática/diagnóstico , Fibrose Pulmonar Idiopática/tratamento farmacológico , Fibrose Pulmonar Idiopática/fisiopatologia , Pulmão/diagnóstico por imagem , Pulmão/fisiopatologia , Masculino , Testes de Função Respiratória/métodos , Avaliação de Sintomas/métodos , Tomografia Computadorizada por Raios X/métodos , Resultado do TratamentoRESUMO
Echinococcus granulosus still remains a widespread disease. Moreover, there is a large number of patients in whom it is diagnosed rather late because its clinical presentation can be unspecific and symptoms vary. We report a familial case of the disease. Its specific feature was the onset with the bilateral pulmonary process and late involvement of the liver. This excluded other pulmonary diseases, such as pneumonia, tuberculosis or cancer.
